Healthcare provider profile · identity verified

Dawn Dust, ARNP

Nurse Practitioner · LAKE CITY, FL · NPI 1730562760

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	95
Levothyroxine Sodium	Levothyroxine Sodium	263	58
Omeprazole	Omeprazole	243	43
Gabapentin	Gabapentin	240	65
Amlodipine Besylate	Amlodipine Besylate	239	62
Eliquis	Apixaban	222	45
Lisinopril	Lisinopril	200	44
Furosemide	Furosemide	183	51
Tamsulosin Hcl	Tamsulosin Hcl	170	35
Carvedilol	Carvedilol	164	36
Trazodone Hcl	Trazodone Hcl	163	41
Pantoprazole Sodium	Pantoprazole Sodium	160	38
Losartan Potassium	Losartan Potassium	151	34
Donepezil Hcl	Donepezil Hcl	150	38
Memantine Hcl	Memantine Hcl	138	28
Potassium Chloride	Potassium Chloride	129	38
Clopidogrel	Clopidogrel Bisulfate	121	29
Metoprolol Tartrate	Metoprolol Tartrate	113	32
Montelukast Sodium	Montelukast Sodium	110	22
Sertraline Hcl	Sertraline Hcl	105	25
Buspirone Hcl	Buspirone Hcl	103	27
Oxybutynin Chloride	Oxybutynin Chloride	97	20
Quetiapine Fumarate	Quetiapine Fumarate	97	29
Levetiracetam	Levetiracetam	93	12
Metoprolol Succinate	Metoprolol Succinate	92	28
Mirtazapine	Mirtazapine	86	18
Famotidine	Famotidine	85	20
Metformin Hcl	Metformin Hcl	80	20
Atenolol	Atenolol	70	12
Duloxetine Hcl	Duloxetine Hcl	60	17
Midodrine Hcl	Midodrine Hcl	59	12
Escitalopram Oxalate	Escitalopram Oxalate	58	suppressed
Hydralazine Hcl	Hydralazine Hcl	57	14
Tizanidine Hcl	Tizanidine Hcl	54	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	53	18
Hydrochlorothiazide	Hydrochlorothiazide	52	13
Amitriptyline Hcl	Amitriptyline Hcl	48	suppressed
Lorazepam	Lorazepam	48	18
Simvastatin	Simvastatin	47	14
Tradjenta	Linagliptin	47	suppressed
Baclofen	Baclofen	46	suppressed
Bumetanide	Bumetanide	45	18
Tramadol Hcl	Tramadol Hcl	44	22
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Divalproex Sodium	Divalproex Sodium	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	15
Torsemide	Torsemide	42	suppressed
Myrbetriq	Mirabegron	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	21
Alprazolam	Alprazolam	40	18
Aripiprazole	Aripiprazole	40	suppressed
Nystatin	Nystatin	38	14
Allopurinol	Allopurinol	37	11
Prednisone	Prednisone	37	15
Bupropion Xl	Bupropion Hcl	36	suppressed
Ranolazine Er	Ranolazine	36	suppressed
Risperidone	Risperidone	35	suppressed
Finasteride	Finasteride	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	27
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Clonazepam	Clonazepam	31	13
Ondansetron Hcl	Ondansetron Hcl	31	15
Primidone	Primidone	29	suppressed
Lactulose	Lactulose	28	11
Pregabalin	Pregabalin	28	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Spironolactone	Spironolactone	26	11
Xarelto	Rivaroxaban	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	suppressed
Ibuprofen	Ibuprofen	25	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Movantik	Naloxegol Oxalate	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Topiramate	Topiramate	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Levofloxacin	Levofloxacin	22	17
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Levemir Flexpen	Insulin Detemir	20	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Letrozole	Letrozole	18	suppressed
Digoxin	Digoxin	17	suppressed
Linzess	Linaclotide	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Azithromycin	Azithromycin	13	12
Creon	Lipase/Protease/Amylase	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Gemtesa	Vibegron	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Azathioprine	Azathioprine	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Rinvoq	Upadacitinib	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error